International Diabetes Summit 2018 – Videos
Familial Hypercholesterolemia

Educational Lecture Series
Familial Hypercholesterolemia
Statins for Diabetes

Educational Lecture Series
Statins for Diabetes
Challenge of the Severely Insulin Resistant Patient

Challenge of the Severely Insulin Resistant Patient - By Michael Alvarsson
Nocturnal Control of Glucose in Type 2 Diabetes

Nocturnal Control of Glucose in Type 2 Diabetes -- By Dr.Rita Basu
Clinical Dilemmas in Diabetes Diagnosis

Clinical Dilemmas in Diabetes Diagnosis - By Dr.Sachin Chittawar
Perioperative Glycemic Control

Perioperative Glycemic Control -- By Dr.Sanjay Agarwal
Diabetes and Psoriasis : Clinical Insights from published evidence

Diabetes and Psoriasis : Clinical Insights from published evidence - By Dr.Sainath
Evolving Landscape of DPP4 inhibitor CVOTs

Evolving Landscape of DPP4 inhibitor CVOTs, Focus on upcoming Clinical Trials - By Dr.Uday Phadke
Cardiovascular effects of Anti Diabetic Drugs

Cardiovascular effects of Anti Diabetic Drugs - By Prof David Lesli
Concentrating on Concentrated Insulins

Concentrating on Concentrated Insulins - Dr.Akshay Jain
Examples of Managing Extreme Obesity

Examples of Managing Extreme Obesity - By Dr.Aparna Govil Bhasker
GLP1 & Bariatrics

Once a week GLP1ra for diabetes in bariatric clinic - Dr.Shashank Shah
Stratifying Diabetes - A primer case of Studies

Stratifying Diabetes - A primer case of Studies
Incretin Effect in Asians

Incretin Effect in Asians
Is it Really Type 2 Diabetes

Is it Really Type 2 Diabetes - By Dr.C.B.Sanjeevi
Managing T2DM Pathophysiologies vs Managing T2DM Complications : same difference ?

Managing T2DM Pathophysiologies vs Managing T2DM Complications : same difference ?
HBA1C Interpretation in Clinical Practice - what we did not know !

HBA1C Interpretation in Clinical Practice - what we did not know !
Prevention of Influenza in Diabetes Patients

WHy it is important to prevent Influenza in Diabetes Patients and How to do it. A practical masterclass
Clinical Approache to Thin young Diabetes.

Clinical Approache to Thin young Diabetes.
Case perspective - treating Diabetes in terminally ill

Case perspective - treating Diabetes in terminally ill
Future of NASH therapies

Future of NASH therapies
Testosterone Treatment in Type 2 Diabetes

Testosterone Treatment in Type 2 Diabetes by Dr.Yashpal Gogate
Screening for sight Threatening Diabetic Retinopathy in 2018

Screening for sight Threatening Diabetic Retinopathy in 2018
How do we manage blood glucose in the diabetic patient with impaired kidney function?

How do we manage blood glucose in the diabetic patient with impaired kidney function?
Targeting renal risk post Metformin : can DPP4i address glycemic instability

Targeting renal risk post Metformin : can DPP4i address glycemic instability
Diabetes and the foot-kidney link

Diabetes and the foot-kidney link
Diabetic Neuropathy – 2018 , New vistas in Diabetes

Diabetic Neuropathy – 2018 , New vistas in Diabetes
Flash glucose monitoring in differing clinical scenarios

Flash glucose monitoring in differing clinical scenarios
Digital connectivity in glucose management

Digital connectivity in Glucose Management
The management of hypoglycaemia – case studies

The management of hypoglycaemia – case studies
Capacity building in chronic conditions

Capacity building in chronic conditions
GLP1ra in the continuum of diabetes care

GLP1ra in the continuum of diabetes care
Once a week GLP1ra for diabetes in a bariatric clinic

Once a week GLP1ra for diabetes in a bariatric clinic
Indian premix guidelines: A practical guide to insulin use in routine clinical care

Indian premix guidelines: A practical guide to insulin use in routine clinical care
R.I.P Basal bolus therapy?

R.I.P Basal bolus therapy?
The hunt for the best basal

The hunt for the best basal
Alternative routes for injectable diabetic therapies

Alternative routes for injectable diabetic therapie
Ultrafast acting insulins: Future directions and clinical outcomes

Ultrafast acting insulins: Future directions and clinical outcomes
The diabetes landscape: a biosimilar perspective

The diabetes landscape: a biosimilar perspective
Can Immunotherapy tackle diabetes?

Can Immunotherapy tackle diabetes?
SGLT2 in T2DM – has the prime time arrived?

SGLT2 in T2DM – has the prime time arrived?
What is the legacy story with OADs?

What is the legacy story with OADs?
Heart failure Hospitalization risk with DPP-4 Inhibitors: Myth or reality?

Heart failure Hospitalization risk with DPP-4 Inhibitors: Myth or reality?
Early intensification with SGLT2i – a logical approach

Early intensification with SGLT2i – a logical approach
HbA1c interpretation in clinical practice – What we did not know!

HbA1c interpretation in clinical practice – What we did not know!
Hypothyroidism management: interpreting Bizarre thyroid function tests

Hypothyroidism management: interpreting Bizarre thyroid function tests
All type 1 diabetes need pump therapy

All type 1 diabetes need pump therapy
All type 1 diabetes do not need pump therapy

All type 1 diabetes do not need pump therapy
Case studies with RT-CGM in type 1 diabetes

Case studies with RT-CGM in type 1 diabetes
SGLT2i in post CANVAS era: focus on renal outcomes

SGLT2i in post CANVAS era: focus on renal outcomes
The artificial pancreas update

The artificial pancreas update
Clinical perspective on using CSII-sensor combination in type 1 diabetes

Clinical perspective on using CSII-sensor combination in type 1 diabetes
The triad story of T2D- variability, hypoglycaemia and clinical outcomes

The triad story of T2D- variability, hypoglycaemia and clinical outcomes
Endocrine hypoglycaemia

Endocrine hypoglycaemia
Approach to common diabetic foot problems

Approach to common diabetic foot problems
Glucose control during dialysis

Glucose control during dialysis
Can medical intervention modify diabetic retinopathy?

Can medical intervention modify diabetic retinopathy?
Interpreting cardiovascular outcome trials in diabetes

Interpreting cardiovascular outcome trials in diabetes
CVD Real – A real-world look at the effectiveness of SGLT-2 inhibitors

CVD Real – A real-world look at the effectiveness of SGLT-2 inhibitors
Popular Courses
Subscribe to receive our latest updates
- © 2024 Chellaram Diabetes Institute.All rights reserved.